Patent · US Active

Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof

US11931465B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

CHILDREN'S NATIONAL MEDICAL CENTER · US

Inventors

Rohan Fernandes · Bethesda, US
Raymond W. Sze · McLean, US
Conrad Russell Y. Cruz · Bethesda, US
Anthony Sandler · Coralville, US
Catherine BOLLARD · Bethesda, US
Elizabeth Sweeney · Washington, US
Juliana Cano-Mejia · Washington, US
Rachel Burga · Washington, US
Matthieu Dumont · Washington, US

Key dates

Filing date	Mar 8, 2017
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Mar 8, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.